Azcuris
PrivateLast Round
Series B
Apr 30, 2026
Est. Valuation
$45.5M
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Azcuris is a biotechnology company that develops first-in-class, small-molecule therapeutics targeting protein-protein interactions to treat immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azcuris Comparables
Compare Azcuris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 76% | |
| Galux | 74% | |
| Odyssey Therapeutics | 69% |
Azcuris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 30, 2026 | ||||
| VC Round | Jun 1, 2021 | ||||
| Series A | Jul 1, 2020 | ||||
| Seed | Nov 1, 2018 |
Key People
Founding team and executive leadership
Azcuris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series B |
| Korea University Holdings | Seed |
| KB Investment | Series B |
| Partners Investment | Series B |
| Atinum Investment | Series B |
| Tech Incubator Program for Startups | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
$4M round led by Atinum Investment and BNH INVESTMENT.
- Jun 1, 2021
Raised $891K in a VC Round.
Recent news
Latest coverage and updates
- is_developingJul 14, 2026
Azcuris is developing innovative therapies for respiratory and Th2-driven diseases on Jul 14th '26.
- partners_withJul 14, 2026
Azcuris partnered with AstraZeneca on Jul 14th '26.
- is_developingJul 14, 2026
Azcuris is developing drug discovery program on Jul 14th '26.
Azcuris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Azcuris's valuation, stock price, and market status.
Is Azcuris a public or private company?
Azcuris is a private company.
What is the current stock price of Azcuris?
Azcuris is a private company with no public stock price. Caplight tracks Azcuris's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Azcuris worth (valuation)?
Azcuris's valuation is estimated at $45.5M based on funding round data.
Can I buy Azcuris stock?
Azcuris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Azcuris's last funding round?
Azcuris's most recent funding round was Series B on April 30, 2026.
Who are the main investors in Azcuris?
Key investors in Azcuris include BNH INVESTMENT, Korea University Holdings, KB Investment, Partners Investment, Atinum Investment.
Will Azcuris IPO soon?
No public IPO plans have been announced for Azcuris.
How can I track Azcuris secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Azcuris's secondary market activity and sign up for updates.